N,N'-((Thiobis(Ethane-2,1-Diyl))Bis(1,3,4-Thiadiazole-5,2-Diyl))Bis(2-Phenylacetamide) N,N’-(硫基双(乙烷-2,1-二基))双(1,3,4-噻二唑-5,2-二基))双(2-苯基乙酰胺)
CAS 314045-39-1 MFCD14045391
化学结构图
SMILES:
化学属性
| Mol. Formula | C24H28N6O2S3 |
|---|
别名和识别编码
| Chemical Name | N,N'-((Thiobis(Ethane-2,1-Diyl))Bis(1,3,4-Thiadiazole-5,2-Diyl))Bis(2-Phenylacetamide) |
|---|---|
| Chemicalbook ID | CB22654238 |
| Chemical Name Translation | N,N’-(硫基双(乙烷-2,1-二基))双(1,3,4-噻二唑-5,2-二基))双(2-苯基乙酰胺) |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. Meghan J. Seltzer, et al. Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1. Cancer Res. 2010 Nov 15; 70(22): 8981-8987.
- [3]. Lee JS, et al. Glutaminase 1 inhibition reduces thymidine synthesis in NSCLC. Biochem Biophys Res Commun. 2016 Aug 26;477(3):374-82
- [4]. Lee JS, et al. Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC. Cell Death Dis. 2016 Dec 8;7(12):e2511.
- [1]. Elgogary A, et al. Combination therapy with BPTES nanoparticles and targets the metabolic heterogeneity of pancreatic cancer. Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):E5328-36.
- [1]. Elgogary A, et al. Combination therapy with BPTES nanoparticles and targets the metabolic heterogeneity of pancreatic cancer. Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):E5328-36.
- [2]. Meghan J. Seltzer, et al. Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1.
